Browsing Tag
Stanford Medicine
2 posts
Shenandoah Therapeutics appoints Steve Worland CEO as BCL6 cancer program nears IND studies
Shenandoah Therapeutics has appointed biotechnology veteran Steve Worland as chief executive officer, with co-founder Isabella Graef moving into the chief scientific officer role. The leadership change comes as the company's BCL6-targeting oncology program approaches IND-enabling studies, creating an important test of its transcriptional and epigenetic drug discovery platform.
How AI is transforming cancer diagnosis and treatment planning in 2025
AI is reshaping cancer care—improving diagnosis, guiding treatment, and boosting efficiency across hospitals. Discover how it's redefining oncology workflows in 2025.